Guinea pigs are routinely used in the histological evaluation of the cochlea as a method of testing for ototoxicity, but the procedures are very time-consuming. Because the avian cochlea is easier to examine and newly hatched chicks are sensitive to the ototoxic effects of gentamicin, birds may be useful in testing for ototoxicity. The use of chicken embryos would be even better for testing, but whether or not chicken embryos are sensitive to ototoxicants is unknown. In an attempt to determine whether or not chicken embryos may be used instead ofguinea pigs in screening tests for ototoxicity, aminoglycoside antibiotics and a loop diuretic, ethacrynic acid, were administered to chicken embryos. A maximum-tolerated dose of gentamicin, kanamycin, streptomycin, ethacrynic acid, or a combination of gentamicin and ethacrynic acid was administered to fertile eggs of White Leghorn chickens on incubation days 10-17. To compare the effect of route ofexposure on ototoxicity, gentamicin was administered by injection into the allantoic space, yolk sac, and air cell as well as by submerging the egg in gentamicin solution. With the preferred air cell route the effects of the ototoxic drugs kanamycin, streptomycin, ethacrynic acid, and a combination of ethacrynic acid and gentamicin were compared. On incubation day 18, cochleas were removed from the chicken embryos. Serial sections of these avian cochleas were examined and hair cells were counted. No significant difference was seen between the number of hair cells in cochleas ofcontrol chicken embryos and those from chicken embryos treated with drugs. Therefore, the chicken embryo appears to be insensitive to the ototoxicity of aminoglycoside antibiotics and a loop diuretic.
INTRODUCTION
Histologic evaluation ofguinea pig organs of Corti is routinely used as a method of testing for ototoxicity (1 8). However, procedures involving the spiral mammalian cochlea are time-consuming and expensive. The avian cochlea is essentially linear and has close functional (1 5) and histologic homology to the mammalian cochlea. The soft petrous bone surrounding the cochlea of the chick allows for easy 48824-1316. removal and rapid processing of the cochlear structures for histologic examination. In addition to this ease of examination, chicks have been shown to respond in a similar fashion as mammals to several otologic insults such as the aminoglycoside antibiotics administration (8, 10) and acoustic trauma (1 7).
Although chicks could potentially serve a role in ototoxicity testing, it would be even simpler if eggs and chicken embryos could be used.
Whether or not chicken embryos are sensitive to aminoglycoside-induced ototoxicity, as are mammals and the chick, is unknown. Aminoglycoside antibiotics have been shown to cross the placenta (29) of humans and produce in zitero ototoxicity without simultaneously producing teratogenicity (1 , 7, 24, 26). Since the chicken embryo cochlea differentiates early, with tall and short hair cells in the 10 cochlea visible in an 1 1-day embryo (6), these cells should be potential targets of otoxicity in the egg as they are in 1 1-day-old chicks following 10 days of gentamicin treatment (8). The purpose of this study was to determine whether or not chicken embryos are susceptible to the ototoxic effects of aminoglycoside antibiotics and/or a loop diuretic.
MATERIALS AND METHODS
Twenty-four fertile White Leghorn chicken eggs (Michigan State University, Poultry Research and Teaching Center, East Lansing, MI, USA) were incubated at 37°C and 85% humidity. Three eggs were randomly assigned to 1 of 8 different treatment groups determined by drug and route of injection (Table I) . The eggs were exposed on incubation days 10-1 7 to maximum-tolerated, nonlethal doses (determined in preliminary unpublished studies) of gentamicin sulfate (G-3632; Sigma Chemical Co., St. Louis, MO, USA), kanamycin sulfate (Kan-trim@, 200 mg/ml; Fort Dodge Laboratories Inc., Fort Dodge, IA, USA), streptomycin sulfate (S-6501; Sigma Chemical Co.), ethacrynate sodium (Sodium Edecrin@, 50 mg; Merck, Sharp, and Dohme, West Point, PA, USA), or ethacrynate sodium and gentamicin sulfate combined. Injection volumes were maintained between 0.1 and 0.2 ml for each treatment group.
On day 18 of incubation, the chicken embryos were killed by decapitation and the brain and lower jaw were dissected away. The ventral skull was sectioned in half along the midline and the temporal bones were isolated and placed in a small dish containing 2% glutaraldehyde in 0.1 M phosphate buffer. The connective tissue immediately posterior to the tympanic-membrane was removed along with the tympanic membrane and the columella, a structure similar to the mammalian auditory ossicles. The remaining cochlea and vestibular structures were surrounded by some cartilage (Fig. 1) . The cartilage separating the round window and oval window was removed, and the lateral aspect of the cochlea was exposed by running fine-pointed forceps along the inside of the linear cartilaginous wall of the cochlea. The cartilage was further dissected and the cochlea was removed.
Following removal, the cochlea was kept in 2% glutaraldehyde in 0.1 M phosphate buffer at 4°C for 4 hr. The cochlea was then rinsed 3 times with 0.1 M phosphate buffer and stored in 0.1 M phosphate buffer at 4°C. Cochleas were postfixed with 1% (w/ v) osmium tetroxide followed by uranyl acetate, dehydrated through graded ethanol, transferred to propylene oxide, and infiltrated with, and embedded in, eponlaraldite resin. After curing for 60 hr at 60°C, transverse sections of the cochlea, which were 1 pm thick, were cut with a diamond knife on an ultramicrotome and stained with Toluidine blue. Transverse sections of the cochlea were made at three levels (20, 40 , and 60% of the total distance) between the apex and the base.
Quantitative hair cell analysis at each of the three levels of the cochlea was done by microscopically viewing each tissue section at a magnification of x 1,000. Tall and short hair cells were combined for total hair cell count, and the following criteria were used to include hair cells in the count (Fig. 2) : presence of a well-formed cell body, extension of the cell to the cuticular plate, and identifiable stereocilia (8). Three transverse sections of cochlea per slide were counted, and the total number of hair cells per transverse section ofcochlea was averaged. Analysis of variance based on a completely random design was used to evaluate for statistical differences (p < 0.05) between the mean hair cell counts of the control and treatment groups.
Samples of kidney were collected from each em- bryo to serve as a positive control of aminoglycoside toxicosis. Samples were placed in 2% glutaraldehyde in 0.1 M phosphate buffer at 4°C for 4 hr, rinsed 3 times with 0.1 M phosphate buffer, processed by a standard histotechnologic method, embedded in paraffin, and sectioned at 7 pm. Sections were stained with hematoxylin and eosin.
RESULTS
No significant (p < 0.05) differences were detected between mean hair cell numbers of cochleas from control chicken embryos and the mean hair cell numbers of cochleas from chicken embryos in the different treatment groups (Fig. 3) . Although no decrease in hair cell numbers was detected in chicken embryos, mild to moderate renal tubular epithelial necrosis and mineralization were common findings in chicken embryos receiving gentamicin, kanamycin, or streptomycin (Fig. 4) .
DISCUSSION
The lack of morphologic alterations induced by streptomycin and other aminoglycoside antibiotics in chicken embryos of this study contrasts previous findings that a single dose of 166 mg of strepto- mycidkg egg weight injected into the center of an egg on days 7-1 1 of incubation resulted in 71% of embryos having hair cell morphologic changes (2 1). In the same study, when chicken embryos were injected with streptomycin on incubation days 12-13, 18% had cochlear lesions, and none ofthose injected with the same dose of streptomycin on incubation days 14-1 5 had cochlear lesions. Since hair cells of chicken embryos were clearly unambiguous by day 11 (6), cytodifferentiation of the hair cells could be interfered with by a drug, resulting in a teratogenic effect rather than a toxicologic effect. Similar teratogenic effects have been produced in mouse cochlear explants when exposed to gentamicin prior to the onset of morphogenesis on day 13 of gestation (2, 3). By day 16 of gestation, morphologic develop- ment had largely ended, and exposure to gentamicin at this point resulted in selective hair cell toxicity similar to that produced in newly hatched chicks.
Marked hair cell loss can be produced by dosing newly hatched chicks with gentamicin (8), kanamycin (lo), and streptomycin (20) , but despite administration of similar aminoglycoside antibiotics and/or the loop diuretic ethacrynic acid by various routes, the chicken embryo appears resistant to ototoxicity induced by these drugs. This change from insensitivity to drug-induced ototoxic changes in the chicken embryo to the sensitivity of newly hatched chicks is a rapid transition. A similar period of insensitivity occurs in rats, but it occurs after birth (19) . The rat cochlea appears to be insensitive to kanamycin ototoxicity between birth and postnatal day 10, with the sensitive period beginning on day 11. This sensitive period to aminoglycoside ototoxicity not only exists in rats (5, 13, 14, 16) but also in mice (1 I), guinea pigs (9, 28), and cats (4). This sensitive period in chicks appears to be the first few days after hatching (8, 10, 27). The appearance of the sensitive period in mammals is marked by the onset of auditory function (14), and the onset of cochlear function coincides with anatomical maturation of the cochlea, especially with the maturation of the outer hair cells, which are generally regarded as the most sensitive to aminoglycoside antibiotic toxicity (1 4, 22) . As in mammals, druginduced hair cell loss in the chick coincides with the period of final development and functional maturation of the cochlea (23, 25) .
Although the insensitivity to drug-induced ototoxic changes in the chick embryo is thought to be due to lack of cochlear anatomical maturation, the exact reason is unknown. The ototoxic insensitivity of the chicken embryo might be due to a lack of drug distribution to the basilar papilla. This is probably not the reason, because there is systemic distribution. of the aminoglycoside antibiotics with nephrotoxic (1 2) effects produced in the kidneys of chicken embryos in all treatment groups. Although future studies are necessary to determine the cause of the ototoxic insensitivity of the chicken embryo, the chicken embryo does not appear to be a good animal to use in screening tests for ototoxicity.
